5DGZ
Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors
5DGZ の概要
| エントリーDOI | 10.2210/pdb5dgz/pdb |
| 関連するPDBエントリー | 5DHJ 5DIA |
| 分子名称 | Serine/threonine-protein kinase pim-1, (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE, PHOSPHATE ION, ... (4 entities in total) |
| 機能のキーワード | pim-1, kinase, atp-competitive, structure-based drug design, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Isoform 2: Cytoplasm. Isoform 1: Cell membrane: P11309 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 35034.56 |
| 構造登録者 | |
| 主引用文献 | Hu, H.,Wang, X.,Chan, G.K.,Chang, J.H.,Do, S.,Drummond, J.,Ebens, A.,Lee, W.,Ly, J.,Lyssikatos, J.P.,Murray, J.,Moffat, J.G.,Chao, Q.,Tsui, V.,Wallweber, H.,Kolesnikov, A. Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. Bioorg.Med.Chem.Lett., 25:5258-5264, 2015 Cited by PubMed Abstract: Pim kinase inhibitors are promising cancer therapeutics. Pim-2, among the three Pim isoforms, plays a critical role in multiple myeloma yet inhibition of Pim-2 is challenging due to its high affinity for ATP. A co-crystal structure of a screening hit 1 bound to Pim-1 kinase revealed the key binding interactions of its indazole core within the ATP binding site. Screening of analogous core fragments afforded 1H-pyrazolo[3,4-c]pyridine (6-azaindazole) as a core for the development of pan-Pim inhibitors. Fragment and structure based drug design led to identification of the series with picomolar biochemical potency against all three Pim isoforms. Desirable cellular potency was also achieved. PubMed: 26459208DOI: 10.1016/j.bmcl.2015.09.052 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.502 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






